Latest Post

NICE eschews Value-Based Assessment for now: Are we ready for consensus?

NICE eschews Value-Based Assessment for now: Are we ready for consensus?

Sometimes standing still is the best way to move forward. Just ask the UK’s National Institute for Health and Care Excellence (NICE), which this month decided against adopting its mooted value-based assessment (VBA) model in favour of a more comprehensive look at how new treatments access the NHS. The VBA model (discussed by my colleague … Continue reading

Recent Posts

Pages

Enter your email address to follow this blog and receive notifications of new posts by email.

Download extract from IHS Flexible Pricing strategies multi client study
Drug Price Erosion Multi Client Study extract download

About This Blog

In this blog, our experts share regular insights on the global life sciences industry. Join us as we look at issues in healthcare policy, market access, pricing and reimbursement and R&D. Comments are welcome!
40 countries covered. Download a sample chapter on Brazil
Download a complimentary white paper on market-access risk ratings
Download a sample of the primary research and analysis on French P&R reform

Follow IHS Life Sciences on Twitter

Follow

Get every new post delivered to your Inbox.

Join 291 other followers